Registry of Lobbyists
Version 1 of 54 (1998-07-22 to 1999-01-28) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA)
409 - 4120 YONGE STREET NORTH YORK, ON M2P 2B8 Canada |
| Telephone number: | 416-223-2333 |
| Fax number: | 416-223-2425 |
| Responsible officer name and position during the period of this registration: | JAMES KEON, PRESIDENT |
| Description of the organization's activities: | THE CANADIAN DRUG MANUFACTURERS ASSOCIATION'S MISSION IS TO PROMOTE AN ENVIRONMENT WHICH SUPPORTS AND ENHANCES THE PROVISION OF AFFORDABLE GENERIC MEDICATIONS TO CANADIANS AND PATIENTS AROUND THE WORLD THROUGH RESEARCH, DEVELOPMENT AND MANUFACTURING OF PHARMACEUTICALS AND FINE CHEMICALS IN CANADA. |
| Organization's membership or classes of membership: | THE CDMA IS COMPOSED OF 21 MEMBER COMPANIES IN THE GENERIC AND BIOPHARMACEUTICAL INDUSTRY, FINE-CHEMICAL COMPANIES AND FINAL DOSAGE COMPANIES. |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | JAMES KEON |
| Position title: | PRESIDENT |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | PAULA REMBACH |
| Position title: | RESEARCH ANALYST |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Name: | JULIE TAM |
| Position title: | DIRECTOR, PROFESSIONAL & SCIENTIFIC AFFAIRS |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Competition Tribunal (CT), Environment Canada, Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Foreign Affairs and International Trade Canada (DFAITC), Hazardous Materials Information Review Commission (HMIRC), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Justice Canada (JC), National Research Council (NRC), Natural Sciences and Engineering Research Council (NSERC), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Revenue Canada (RC), Statistics Canada (StatCan), Treasury Board Of Canada Secretariat (TBS), Western Economic Diversification Canada (WD) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Science and Technology, Small Business, Taxation and Finance |
| Subject Matter: Retrospective: | DISCUSSIONS WITH THERAPEUTICS PRODUCTS PROGRAMME OF HEALTH CANADA AND INDUSTRY CANADA RE: ONGOING EXCHANGE OF MATERIAL RE: PATENT RESTRICTIONS IN GENERIC PHARMACEUTICAL EXPORTS; PATENT ACT - DISCUSSION WITH GOV'T OFFICIALS RE: PMPRB (PATENTED MEDICINE PRICES REVIEW BOARD) - ONGOING REVIEW OF NOTICE OF COMPLIANCE REGULATIONS - BRIEFS TO GOV'T ON REGULATORY APPROVAL PROCESS FOR GENERIC MEDICINES. |
| Subject Matter: Prospective: | INTERPRETATION & APPLICATION OF TRADE AGREEMENTS WITH THE GENERIC RX INDUSTRY, E.G. CHALLENGE OF CANADA'S PATENT ACT BY EU - CONTINUATION OF NOC REGULATIONS, PATENT ACT, ANTI COMPETITIVE BEHAVIOUR, DRUG REGULATORY REVIEWN PROCESS. |
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
| Name | From | To |
|---|---|---|
| Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG) | 2024-04-01 | current |
| Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG) | 2008-08-01 | 2024-04-01 |
| CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA) | 2008-08-01 | 2008-08-01 |
| Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
|---|
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.